Compass Pathways
CMPS
108 hedge funds and large institutions have $73.8M invested in Compass Pathways in 2022 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 19 increasing their positions, 25 reducing their positions, and 15 closing their positions.
13% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 15
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
1% less funds holding
Funds holding: 109 → 108 (-1)
2.4% less ownership
Funds ownership: 18.46% → 16.06% (-2.4%)
24% less repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 25
26% less capital invested
Capital invested by funds: $100M → $73.8M (-$26.4M)
68% less call options, than puts
Call options by funds: $3.47M | Put options by funds: $11M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$3.96M |
| 2 |
SCM
Saba Capital Management
New York
|
+$3.81M |
| 3 |
RCMNY
Rubric Capital Management (New York)
New York
|
+$2.86M |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
+$2.07M |
| 5 |
NAMA
Nikko Asset Management Americas
New York
|
+$917K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Victory Capital Management
San Antonio,
Texas
|
-$11.6M |
| 2 |
AFM
Anson Funds Management
Dallas,
Texas
|
-$4.84M |
| 3 |
Morgan Stanley
New York
|
-$3.38M |
| 4 |
Two Sigma Investments
New York
|
-$2.63M |
| 5 |
Group One Trading
Chicago,
Illinois
|
-$1.19M |
CMPS Hedge Fund Activity: Q2 2022 in Review
108 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Compass Pathways (CMPS) for Q2 2022, worth a combined $73.8M — down 26% from $100M a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new CMPS positions and 15 closed out — a net gain of 2 holders — while 19 added to existing stakes and 25 trimmed.
The largest buyer was PFM Health Sciences, opening a new position worth an estimated $3.96M. The largest seller was Victory Capital Management, exiting entirely with an estimated $11.6M sold.
- 108 institutional investors held Compass Pathways (CMPS) as of Q2 2022, down from 109 in Q1 2022.
- Funds reported $73.8M of Compass Pathways stock for Q2 2022, down 26% quarter-over-quarter.
- 17 funds opened new Compass Pathways positions in Q2 2022 and 15 closed out, a net change of +2 holders.
- The largest Compass Pathways buyer in Q2 2022 was PFM Health Sciences, an estimated $3.96M added.
- The largest Compass Pathways seller in Q2 2022 was Victory Capital Management, an estimated $11.6M sold.
Based on aggregated 13F filings for Q2 2022.